As at 10:57 AM on 8/9/2010
The Share Price is: 27.50 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
Biofusion Launches Absynth Biologics to Focus on New Treatments for MRSA infection
01 Feb 2007
Cardiff Agreement passed by shareholders at EGM
08 Jan 2007
BIOFUSION ANNOUNCES EXCLUSIVE 10 YEAR DEAL WITH CARDIFF UNIVERSITY
30 Nov 2006
Biofusion pre-liminary results to 31 July 2006
18 Oct 2006
Axordia stem cells available from UK Stem Cell Bank
16 Oct 2006
Diurnal anounces Phase II trial for Chronocort
11 Oct 2006
Medaphor launch first groundbreaking ultrasound training module
09 Oct 2006
Celltran and Xcellentis successfully complete merger
03 Oct 2006
Axordia and Lombard Medical receive significant funding for stent development
02 Oct 2006
Biofusion launches Phase Focus
26 Sep 2006